Trial Profile
A prospective, observational trial assessing the use of onabotulinum toxin A (Botox) in the treatment of chronic migraine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 09 Mar 2017 New trial record